digital currency news Top Top stories

South Korean courts issued arrest warrants for police chief Zhao Zhihao and Seoul police chief Jin Feng Yong. On December 13th, local time, Seoul Central District Court issued arrest warrants for police chief Zhao Zhihao and Seoul police chief Jin Feng Yong. (CCTV News)Russian Ministry of Defence: Russian armed forces occupied seven settlements in one week.Nearly 30 listed companies announced after-hours that their products would be selected, and the tenth batch of centralized drug procurement (centralized drug procurement) organized by the state was opened in Shanghai yesterday. According to incomplete statistics, as of press time, it includes Fuyuan Pharmaceutical, Yifan Pharmaceutical, ST Tiansheng, Hokuriku Pharmaceutical, Haizheng Pharmaceutical, Zhongheng Group, Yuandong Bio, Kelun Pharmaceutical, China Resources Shuanghe, Sinopharm Modern, Lingkang Pharmaceutical, Xuantai Pharmaceutical, Jiuzhou Pharmaceutical, Kang Enbei, Laimei Pharmaceutical, Kanghong Pharmaceutical, Huasen Pharmaceutical, Borui Pharmaceutical, Xianzeng Pharmaceutical. Among them, Kelun Pharmaceutical announced that 12 kinds of drugs, such as sodium acetate Ringer injection, sodium bicarbonate Ringer injection and gliclazide tablets, were to be selected.

The grain output of Inner Mongolia exceeded 80 billion Jin for the first time. The reporter learned from the Agriculture and Animal Husbandry Department of Inner Mongolia Autonomous Region on December 13th that according to the latest data released by the National Bureau of Statistics, the grain output of Inner Mongolia exceeded 80 billion Jin for the first time this year, reaching 82.01 billion Jin, achieving a bumper harvest for 21 consecutive years. (Xinhua News Agency)Liu Jianchao met with Egyptian Foreign Minister Abdul Ati. On December 13th, Liu Jianchao, Minister of the International Liaison Department of the CPC Central Committee, met with Egyptian Foreign Minister Abdul Ati in Beijing. The two sides exchanged views on implementing the important consensus of the two heads of state, strengthening inter-party exchanges, strengthening political dialogue and humanities exchanges, and promoting the construction of a community of destiny between China and Egypt facing the new era. (Xinhua News Agency)Two States in the United States sued Glock, a gun manufacturer, for ignoring the design flaw that "pistols can easily become machine guns". On the 12th, the prosecutors in New Jersey and Minnesota respectively sued Glock, an Austrian weapons manufacturer, accusing the pistol manufactured by them of design defects and being easily converted into illegal machine guns. According to the complaint, Glock knew this situation for a long time, and continued to sell this pistol to the United States and profit from it, which promoted the proliferation of gun violence in the United States. (Xinhua News Agency)

Market news: South Korean court issued an arrest warrant to Seoul police chief.Hikvision: The controlling shareholder has obtained a commitment letter for a special loan of 120 million yuan to increase its holdings. Hikvision announced that the company recently received a notice from the controlling shareholder, CLP Hikvision, that CLP Hikvision has obtained a commitment letter for a special loan to increase its holdings issued by China Industrial and Commercial Bank of China. Hangzhou Branch of Industrial and Commercial Bank of China will provide a loan fund of no more than 120 million yuan for CLP Hikvision Group to increase its shareholding in Hikvision by centralized bidding, and the loan period will not exceed 3 years.Kexing launched the world's first phase III clinical study of bivalent inactivated enterovirus vaccine. On December 13th, the first volunteer was enrolled in the phase III clinical study of bivalent inactivated enterovirus vaccine developed by Beijing Kexing Biological Products Co., Ltd., a subsidiary of Kexing Holding Biotechnology Co., Ltd. (hereinafter referred to as "Kexing"). The vaccine is used to prevent hand, foot and mouth disease caused by enterovirus 71 (EV71) and coxsackie virus 16 (CA16). A multicenter, randomized, double-blind, controlled study design was adopted in this phase III clinical study to evaluate the protective efficacy, safety and immunogenicity of the vaccine in children aged 6-71 months.